Maybe not the nearly 10 per cent down bubble Pfizer expects, but perhaps a 5 to 7.5 per cent headwind others are seeing for 2015. That's likely to be Kenilworth's experience in 2015, too.
Yes. Even with solid hedging in place -- you read it here first. Currencies will be a challenge for US domiciled multinationals in 2015.
Now, go out and have a great day! Just a quick prediction -- as we head into pharma and biotech earnings release season.
Thursday, January 29, 2015
As Other Majors Post Q4 2014 Results, I'd Expect Merck To Forecast Strong Headwinds, In Currencies -- In 2015
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment